--- ...

By Michael Erman and Christy Santhosh Jan 20 (Reuters) - Novavax said on Tuesday it signed a licensing agreement allowing ...

Novavax Inc (NASDAQ:NVAX) shares are trading higher. Reports show a rise in respiratory illnesses across the United States.

Pfizer will now employ Novavax’s adjuvant, Matrix-M, into its vaccines across two disease areas.

If you are wondering whether Novavax at around US$7.25 is a bargain or a value trap, you are not alone. This article focuses on what the current price really implies about the company. The stock has ...

Brand Engagement Network, Inc. (Nasdaq: BNAI) ("BEN"), a provider of secure, governed conversational AI solutions for ...

Jan 19 (Reuters) - French drugmaker Valneva said on Monday it has voluntarily withdrawn its application seeking standard ...

Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine ...

The sixth edition of the World Baseball Classic will be played in March 2026, three years after a thrilling 2023 finale between USA and Japan. That, of course, ended when Shohei Ohtani struck out then ...

A webcast of the presentation will be available on the Events & Presentations page of the Company's website at ir.novavax.com. A replay of the webcast will be available for 30 days.